XML 56 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business, Acquisition of Assets and Basis of Presentation (Tables)

12 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Company's Allocation on Consideration Transferred for ProstaScint

The Company’s allocation on consideration transferred for ProstaScint as of the purchase date May 20, 2015 is as follows:

		Estimated Fair Value
Tangible assets		$	727,000
Intangible assets			1,590,000
Goodwill			74,000
Total assets acquired		$	2,391,000

Unaudited Pro-forma Information

Pro Forma Information

The unaudited pro-forma results presented below include the effects of the ProstaScint acquisition as if it has been consummated as of July 1, 2013, with adjustments to give effect to pro forma events that are directly attributable to the acquisition which includes adjustments related to the amortization of acquired intangible assets. The unaudited pro forma results do not reflect any operating efficiency or potential cost savings which may result from the consolidation of ProstaScint. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations and are not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been consummated as of July 1, 2013.

		Years ended June 30,
		2015				2014
Total revenue		$	1,371,106			$	1,736,139
Expenses
Cost of sales - ProstaScint			1,818,690				2,054,786
Research and development			3,065,626				3,933,619
Research and development - related party (Note 8)			156,988				125,587
General and administrative			4,417,884				2,388,665
Amortization and impairment of intangible assets			131,989				100,000
Loss from operations			(8,220,071	)			(6,866,518	)
Interest (expense) income			(114,994	)			(45,553	)
Net loss, before income tax			(8,335,065	)			(6,912,071	)
Deferred income tax benefit			23,910				813,697
Net loss		$	(8,311,155	)		$	(6,098,374	)

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 10



-Section 50



-Paragraph 2



-Subparagraph (h)(2)-(3)



-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 20



-Section 50



-Paragraph 1



-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration